Corrected TIMI frame count does not predict 30-day adverse outcomes after reperfusion therapy for acute myocardial infarction

American Heart Journal

Volumn 138, Issue 4 I, 1999, Pages 785-790

  Bhatt, D L ^a   Ellis, S G ^a   Ivanc, T B ^a   Crowe, T ^a   Balazs, E ^a   Debowey, D ^a   Pangerl, A ^a   Chew, P H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; HEPARIN; LANOTEPLASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD FLOWMETRY; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DOUBLE BLIND PROCEDURE; FEMALE; FIBRINOLYTIC THERAPY; HEART MUSCLE REPERFUSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; REPRODUCIBILITY; TREATMENT OUTCOME;

EID: 0032886718     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70197-3     Document Type: Article

References (37)

1. TIMI Study Group. The Thrombolysis In Myocardial Infarction (TIMI) Trial. N Engl J Med 1985;312:932-6.
2. GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329:1615-22.
3. Simes RJ, Topol EJ, Holmes DR, et al, for the GUSTO-I Investigators. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Circulation 1995;91:1923-8.
4. DeRouen TA, Murray JA, Owen W. Variability in the analysis of coronary arteriograms. Circulation 1977;55:324-8.
5. Hackworthy RA, Sorensen SG, Fitzpatrick PB, et al. Dependence of assessment of coronary artery reperfusion on angiographic criteria and interobserver variability. Am J Cardiol 1988;62:538-42.
6. Reiner JS, Lundergan CF, Fung A, et al. Evolution of early TIMI 2 flow after thrombolysis for acute myocardial infarction. Circulation 1996;94:2441-6.
7. Gibson CM, Cannon CP, Daley WL, et al, for the TIMI 4 Study Group. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996;93:879-88.
8. Ellis SG, Topol EJ, George BS, et al. Recurrent ischemia without warning: analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator. Circulation 1989;80:1159-65.
9. Gibson CM, Cannon CP, Baim DS, et al, for TIMI-4 Investigators. TIMI frame count: a new standardization of infarct-related artery flow grade and its relationship to clinical outcomes in the TIMI-4 trial [abstract]. Circulation 1994;90:I-220.
10. Gibson M, Cannon CP, Marble SJ, et al, for the TIMI 4 Investigators. The corrected TIMI frame count (cTFC) predicts clinical outcomes in acute MI [abstract]. Circulation 1996;94:I-441.
11. Cannon CP, McCabe CH, Gibson CM, et al, for the TIMI 10A Investigators. TNK-Tissue plasminogen activator in acute myocardial infarction: results of the thrombolysis in myocardial infarction (TIMI) 10A dose-ranging trial. Circulation 1997;95:351-6.
12. Gibson M, Goel M, Dotani I, et al, for the RESTORE Investigators. The post-PTCA TIMI frame count and mortality in RESTORE [abstract]. Circulation 1996;94:I-85.
13. Vogt A, von Essen R, Tebbe U, et al. Impact of early reperfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of 4 German multicenter studies. J Am Coll Cardiol 1993;21:1391-5.
14. Lincoff AM, Topol EJ. Trickle down thrombolysis. J Am Coll Cardiol 1993;21:1396-8.
15. Karagounis L, Sorensen SG, Menlove RL, et al, for the TEAM-2 Investigators. Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. J Am Coll Cardiol 1992;19:1-10.
16. Fath-Ordoubadi F, Huehns TY, Al-Mohammad A, et al. TIMI grade 2 flow is not equivalent to TIMI 3: implications for the use of thrombolytic therapy: a meta-analysis of the trials [abstract]. J Am Coll Cardiol 1995;25:401A.
17. Lincoff AM, Topol EJ, Califf RM, et al, for the TAMI Study Group. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the Thrombolysis and Angioplasty in Myocardial Infarction Trials). Am J Cardiol 1995;75:871-6.
18. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992;85:1699-705.
19. Ito H, Okamura A, Iwakura K, et al. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation 1996;93:1993-9.
20. Anderson JL, Karagounis LA, Becker LC, et al, for the TEAM-3 Investigators. TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Circulation 1993;87:1829-39.
21. White CW. Simplicity's virtue scorned: precision comes to TIMI flow grading and the results are surprising. Circulation 1996;93:853-6.
22. Gibson CM, Cannon CP, Piana RN, et al, for the TIMI 4 Study Group. Angiographic predictors of reocclusion after thrombolysis: results from the thrombolysis in myocardial infarction (TIMI) 4 trial. J Am Coll Cardiol 1995;25:582-9.
23. Ellis SG, Pinto IMF, McGillem MJ, et al. Accuracy and reproducibility of quantitative coronary arteriography using 6 and 8 French catheters with cine angiographic acquisition. Cathet Cardiovasc Diagn 1991;22:52-5.
24. Hodgson JM, Mancini GBJ, Legrand V, et al. Characterization of changes in coronary blood flow during the first 6 seconds after intracoronary contrast injection. Invest Radiol 1985;20:246-52.
25. Sheehan F, Guo AL, Every NR, et al, for the ESCALAT Investigators. Consideration of heart rate improves accuracy of TIMI frame count for assessing coronary artery flow in patients with acute myocardial infarction [abstract]. Circulation 1996;94:I-23.
26. Huizenga A, Aengevaeren WRM, van der Werf T, et al. Does TIMI frame count reflect myocardial blood flow [abstract]? J Am Coll Cardiol 1997;29:132A.
27. Krucoff MW, Croll MA, Pope JE, et al. Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations. Am J Cardiol 1993;71:145-51.
28. Krucoff MW, Croll MA, Pope JE, et al, for the TAMI 7 Study Group. Continuous 12-lead ST-segment recovery analysis in the TAMI 7 study: performance of a noninvasive method for realtime detection of failed myocardial reperfusion. Circulation 1993;88:437-46.
29. Lee KL, Woodlief LH, Topol EJ, et al, for the GUSTO-I Investigators. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41,021 patients. Circulation 1995;91:1659-68.
30. Reimer KA, Jennings RB, Cobb FR, et al. Animal models for protecting ischemic myocardium: results of the NHLBI cooperative study. Circ Res 1985;56:651-65.
31. Murray CE, Jennings RB, Reimer KA. New insights into potential mechanisms of ischemic preconditioning. Circulation 1991;84:442-5.
32. Mancini GBJ. Quantitative coronary arteriographic methods in the interventional catheterization laboratory: an update and perspective. J Am Coll Cardiol 1991;17:23B-33B.
33. Wilson RF, Laxson DD, Lesser JR, et al. Intense microvascular constriction after angioplasty of acute thrombotic coronary arterial lesions. Lancet 1989:807-11.
34. Topol EJ, Nissen SE. Our preoccupation with coronary luminology: the dissociation between clinical and angiographic findings in ischemic heart disease. Circulation 1995;92:2333-42.
35. Gibson M, Daley WL, Rizzo M, et al, for the RESTORE Investigators. Flow following primary PTCA for acute MI [abstract]. Circulation 1996;94:I-670.
36. Gibson M, Rizzo M, McLean C, et al, for the RESTORE Investigators. Flow in culprit arteries following PTCA is faster than that in nonculprit arteries: timing and magnitude of hyperemia [abstract]. J Am Coll Cardiol 1997;29:18A.
37. Goel M, Rizzo M, McLean C, et al, for the RESTORE Investigators. Non-culprit artery blood flow in acute coronary syndromes is related to culprit artery blood flow: a RESTORE substudy [abstract]. J Am Coll Cardiol 1997;29:13A.